Independent Director · Lexeo Therapeutics, Inc. (LXEO)

Chair, Science and Technology Committee

Brenda Cooperstone, M.D — Lexeo Therapeutics Director Compensation (2025)

Fiscal year 2025 director compensation for Brenda Cooperstone, M.D at Lexeo Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Brenda Cooperstone, M.D’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Brenda Cooperstone, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Lexeo Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Lexeo Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$58,000$0$81,361$0$139,361
FY2024$58,000$0$217,314$0$275,314
FY2023$18,908$0$493,103$17,125$529,135

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lexeo Therapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-193930, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Lexeo Therapeutics, Inc. filed document, accession 0001193125-26-193930. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Get the Lexeo Therapeutics Board Governance Report

$139,361 Brenda Cooperstone, M.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Lexeo Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Nominating/Governance · Science and Technology (Chair)

The rest of the Lexeo Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Dr. Sepp-LorenzinoIndependent Director—
Mette Kirstine AggerIndependent Director$140,861
Paula HJ CholmondeleyIndependent Director$140,975
R. Nolan TownsendDirector—
Reinaldo DiazIndependent Director$140,861
Steven Altschuler, M.DIndependent Director$163,361
Tim Van HauwermeirenIndependent Director$120,579
Tolga TangulerIndependent Director$88,845

The full Lexeo Therapeutics compensation record

free company brief

This page is one director within Lexeo Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order LXEO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report